{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:28:50Z","timestamp":1768825730094,"version":"3.49.0"},"reference-count":22,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) remains the standard of care for multiple myeloma (MM) patients. Although outpatient ASCT has been shown to be safe and feasible, the procedure is overall rare with most patients in the US undergoing inpatient ASCT. Furthermore, hospitalization rates for patients that undergo outpatient ASCT remain high. Adequate markers that predict hospitalization during outpatient ASCT are lacking, yet would be of great clinical value to select patients that are suited to outpatient ASCT. In this study we aimed to elucidate differences between planned outpatient and inpatient ASCT and further evaluated clinical characteristics that are significantly associated with hospitalization during planned outpatient hospitalization. Factors that were significantly associated with a planned inpatient ASCT included an advanced MM disease stage, worse performance status as well as non-Caucasian race, while low albumin levels and female gender were significantly associated with hospitalization during outpatient ASCT. The results of this analysis provide crucial knowledge of factors that are associated with planned inpatient ASCT and hospitalization during outpatient ASCT and could guide the treating physician in decision-making and further facilitate outpatient transplantation.<\/jats:p>","DOI":"10.3390\/jcm11061640","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T03:34:13Z","timestamp":1647401653000},"page":"1640","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission"],"prefix":"10.3390","volume":"11","author":[{"given":"Kristin","family":"Larsen","sequence":"first","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8176-881X","authenticated-orcid":false,"given":"Horace","family":"Spencer","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Mohan","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Cancer Center, Froedtert Hospital, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clyde","family":"Bailey","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Hill","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Kottarathara","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Parikh","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadiqul","family":"Hoque","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Erra","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Mitma","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Mathur","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Yarlagadda","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravani","family":"Gundarlapalli","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetunde","family":"Ogunsesan","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munawwar","family":"Hussain","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishanth","family":"Thalambedu","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskirat","family":"Sethi","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-8042","authenticated-orcid":false,"given":"Samer","family":"Al Hadidi","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmilan","family":"Thanendrarajan","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Graziutti","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Zangari","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits","family":"van Rhee","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Tricot","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-1741","authenticated-orcid":false,"given":"Carolina","family":"Schinke","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","article-title":"Multiple myeloma current treatment algorithms","volume":"10","author":"Rajkumar","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"N. Engl. J Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbmt.2014.12.026","article-title":"Management of relapsed multiple myeloma after autologous stem cell transplant","volume":"21","author":"Holstein","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41375-020-1005-8","article-title":"Salvage second transplantation in relapsed multiple myeloma","volume":"35","author":"Dhakal","year":"2020","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbmt.2015.03.020","article-title":"National survey of hematopoietic cell transplantation center personnel, infrastructure, and models of care delivery","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1700900","article-title":"Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma","volume":"20","author":"Jagannath","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bmt.1701191","article-title":"Reduced charges and costs associated with outpatient autologous stem cell transplantation","volume":"21","author":"Meisenberg","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbmt.2012.12.006","article-title":"Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ejh.12970","article-title":"Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"99","author":"Shah","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0000000000000305","article-title":"Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma","volume":"11","author":"Khouri","year":"2017","journal-title":"Curr. Opin. Support Palliat. Care."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clml.2015.05.006","article-title":"Outpatient autologous stem cell transplantation for patients with myeloma","volume":"15","author":"Paul","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bmt.2015.46","article-title":"Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma","volume":"50","author":"Graff","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/bmt.2016.79","article-title":"Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma","volume":"51","author":"Martino","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbmt.2013.12.557","article-title":"Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma","volume":"20","author":"Saad","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bbmt.2017.06.001","article-title":"Evaluation of performance status and hematopoietic cell transplantation specific comorbidity index on unplanned admission rates in patients with multiple myeloma undergoing outpatient autologous stem cell transplantation","volume":"23","author":"Obiozor","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00277-020-04180-6","article-title":"Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation","volume":"99","author":"Apolito","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clml.2017.06.012","article-title":"Olanzapine reduces chemotherapy-induced nausea and vomiting compared with aprepitant in myeloma patients receiving high-dose melphalan before stem cell transplantation: A retrospective study","volume":"17","author":"Trifilio","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2019.08.010","article-title":"Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials","volume":"121","author":"Davidson","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2013.098608","article-title":"Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: The IFM experience on 2316 patients","volume":"99","author":"Chretien","year":"2014","journal-title":"Haematologica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clon.2020.05.004","article-title":"Obesity and cancer treatment outcomes: Interpreting the complex evidence","volume":"32","author":"Slawinski","year":"2020","journal-title":"Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ijc.22968","article-title":"Body mass index and risk of multiple myeloma: A meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/6\/1640\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:17Z","timestamp":1760135837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/6\/1640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["jcm11061640"],"URL":"https:\/\/doi.org\/10.3390\/jcm11061640","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}